Laronib 100mg Larotrectinib Capsule In Pakistan

Laronib 100mg Larotrectinib Capsule In Pakistan

Laronib 100mg Larotrectinib Capsule contains larotrectinib, a targeted kinase inhibitor used for certain solid tumors with a neurotrophic tyrosine receptor kinase (NTRK) gene fusion. It may be used in eligible adult and pediatric patients when tumors are metastatic, surgery would likely cause severe morbidity, and there are no satisfactory alternative treatments or the disease has progressed following treatment.

Larotrectinib works by inhibiting TRK proteins produced from abnormal NTRK gene fusions, which can help interfere with signaling involved in tumor-cell growth. Treatment should be initiated by an oncologist or physician experienced in anticancer therapies.

Benefits

• Contains 100mg larotrectinib per capsule.
• Targeted therapy designed for tumors with qualifying NTRK gene fusions.
• Can be used in eligible adult and pediatric patients.
• Oral capsule formulation provides a convenient route of administration.
• May be considered when conventional treatment options are unsuitable or the cancer has progressed following treatment.

Specification

• Brand: Laronib
• Active Ingredient: Larotrectinib
• Salt: Larotrectinib sulfate
• Strength: 100mg
• Dosage Form: Hard capsule
• Route: Oral
• Therapeutic Class: TRK kinase inhibitor / targeted anticancer therapy
• Indication: Selected solid tumors with NTRK gene fusion
• Prescription Status: Prescription medicine
• Equivalent Salt Amount: 100mg larotrectinib is equivalent to approximately 123mg larotrectinib sulfate in the capsule formulation.

How to Use

Take Laronib exactly as prescribed by your oncologist. The recommended adult and pediatric dose for patients with a body surface area of at least 1 m² is 100mg orally twice daily; pediatric dosing may differ based on body surface area.

Capsules should be swallowed whole with water and should not be chewed or crushed. Larotrectinib can generally be taken with or without food, at approximately the same times each day.

If a dose is missed and the next scheduled dose is within 6 hours, the missed dose should not be made up. If vomiting occurs after taking a dose, the next dose should be taken at the usual scheduled time.

Dosage adjustments may be required in certain situations, including moderate or severe liver impairment and some drug interactions. Do not change the dose without medical advice.

Why Choose Laronib?

• Contains the targeted anticancer ingredient larotrectinib.
• 100mg oral capsule presentation.
• Designed for molecularly selected cancers with qualifying NTRK gene fusions.
• Provides an oral treatment option for eligible patients.
• Larotrectinib is an established targeted therapy with approved use in selected NTRK fusion-positive solid tumors.